DDrare
Disease
Drug
Target Gene/Pathway
Contact
JA
Target Gene/Pathway
Pathway
/
Gene
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
entries per page:
Showing 1 to 4 of 4 entries
Filter by
Reset
|
No.
KEGG GENES
KEGG PATHWAY
KEGG DRUG
DrugBank
Disease ID
1
JAK2
💬
1.
JAK2
×
Name
Full Name
JAK2
Janus kinase 2
[24]
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
Chemokine signaling pathway
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Signaling pathways regulating pluripotency of stem cells
,
JAK-STAT signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Cholinergic synapse
,
Prolactin signaling pathway
,
Adipocytokine signaling pathway
,
AGE-RAGE signaling pathway in diabetic complications
,
Growth hormone synthesis, secretion and action
,
Leishmaniasis
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis B
,
Influenza A
,
Kaposi sarcoma-associated herpesvirus infection
,
Herpes simplex virus 1 infection
,
Pathways in cancer
,
Chemical carcinogenesis - receptor activation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
Lipid and atherosclerosis
[24]
EGFR tyrosine kinase inhibitor resistance
,
Chemokine signaling pathway
,
PI3K-Akt signaling path
...
Ruxolitinib
Ruxolitinib
💬
1.
JAK2
×
Name
Other Names
Ruxolitinib
Ruxolitinib (USAN/INN)
Ruxolitinib
[3]
60
60
,
65
,
228
💬
1.
JAK2
×
Disease ID
Name
60
Aplastic anemia
65
Primary immunodeficiency
228
Bronchiolitis obliterans
2
JAK2
💬
2.
JAK2
×
Name
Full Name
JAK2
Janus kinase 2
[24]
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
Chemokine signaling pathway
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Signaling pathways regulating pluripotency of stem cells
,
JAK-STAT signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Cholinergic synapse
,
Prolactin signaling pathway
,
Adipocytokine signaling pathway
,
AGE-RAGE signaling pathway in diabetic complications
,
Growth hormone synthesis, secretion and action
,
Leishmaniasis
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis B
,
Influenza A
,
Kaposi sarcoma-associated herpesvirus infection
,
Herpes simplex virus 1 infection
,
Pathways in cancer
,
Chemical carcinogenesis - receptor activation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
Lipid and atherosclerosis
[24]
EGFR tyrosine kinase inhibitor resistance
,
Chemokine signaling pathway
,
PI3K-Akt signaling path
...
Tofacitinib
Tofacitinib
💬
2.
JAK2
×
Name
Other Names
Tofacitinib
Tofacitinib (USAN)
Tasocitinib
Tofacitinib
[15]
11
11
,
40
,
44
,
46
,
49
,
50
,
51
,
53
,
65
,
84
,
96
,
97
,
107
,
271
,
300
💬
2.
JAK2
×
Disease ID
Name
11
Myasthenia gravis
40
Takayasu arteritis
44
Wegener granulomatosis
46
Malignant rheumatoid arthritis
49
Systemic lupus erythematosus
50
Dermatomyositis
51
Scleroderma
53
Sjogren syndrome
65
Primary immunodeficiency
84
Sarcoidosis
96
Crohn disease
97
Ulcerative colitis
107
Juvenile idiopathic arthritis
271
Ankylosing spondylitis
300
IgG4-related disease
3
JAK2
💬
3.
JAK2
×
Name
Full Name
JAK2
Janus kinase 2
[24]
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
Chemokine signaling pathway
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Signaling pathways regulating pluripotency of stem cells
,
JAK-STAT signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Cholinergic synapse
,
Prolactin signaling pathway
,
Adipocytokine signaling pathway
,
AGE-RAGE signaling pathway in diabetic complications
,
Growth hormone synthesis, secretion and action
,
Leishmaniasis
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis B
,
Influenza A
,
Kaposi sarcoma-associated herpesvirus infection
,
Herpes simplex virus 1 infection
,
Pathways in cancer
,
Chemical carcinogenesis - receptor activation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
Lipid and atherosclerosis
[24]
EGFR tyrosine kinase inhibitor resistance
,
Chemokine signaling pathway
,
PI3K-Akt signaling path
...
Baricitinib
Baricitinib
💬
3.
JAK2
×
Name
Other Names
Baricitinib
Baricitinib (JAN/USAN/INN)
Olumiant (TN)
OTHER BARICITINIB
Baricitinib
[13]
2
2
,
41
,
46
,
49
,
50
,
51
,
53
,
93
,
107
,
162
,
265
,
269
,
325
💬
3.
JAK2
×
Disease ID
Name
2
Amyotrophic lateral sclerosis
41
Giant cell arteritis
46
Malignant rheumatoid arthritis
49
Systemic lupus erythematosus
50
Dermatomyositis
51
Scleroderma
53
Sjogren syndrome
93
Primary biliary cholangitis
107
Juvenile idiopathic arthritis
162
Pemphigoid
265
Lipodystrophy
269
Pyogenic arthritis
325
Hereditary autoinflammatory syndrome
4
JAK2
💬
4.
JAK2
×
Name
Full Name
JAK2
Janus kinase 2
[24]
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
Chemokine signaling pathway
,
PI3K-Akt signaling pathway
,
Necroptosis
,
Signaling pathways regulating pluripotency of stem cells
,
JAK-STAT signaling pathway
,
Th1 and Th2 cell differentiation
,
Th17 cell differentiation
,
Cholinergic synapse
,
Prolactin signaling pathway
,
Adipocytokine signaling pathway
,
AGE-RAGE signaling pathway in diabetic complications
,
Growth hormone synthesis, secretion and action
,
Leishmaniasis
,
Toxoplasmosis
,
Tuberculosis
,
Hepatitis B
,
Influenza A
,
Kaposi sarcoma-associated herpesvirus infection
,
Herpes simplex virus 1 infection
,
Pathways in cancer
,
Chemical carcinogenesis - receptor activation
,
PD-L1 expression and PD-1 checkpoint pathway in cancer
,
Lipid and atherosclerosis
[24]
EGFR tyrosine kinase inhibitor resistance
,
Chemokine signaling pathway
,
PI3K-Akt signaling path
...
Peficitinib
Peficitinib
💬
4.
JAK2
×
Name
Other Names
Peficitinib
Peficitinib (USAN/INN)
Peficitinib
[1]
46
46
💬
4.
JAK2
×
Disease ID
Name
46
Malignant rheumatoid arthritis